OBSV vs. BNOX, CYCN, ADXN, CMMB, TENX, NCNA, EFTR, ASLN, HEPA, and CANF
Should you be buying ObsEva stock or one of its competitors? The main competitors of ObsEva include Bionomics (BNOX), Cyclerion Therapeutics (CYCN), Addex Therapeutics (ADXN), Chemomab Therapeutics (CMMB), Tenax Therapeutics (TENX), NuCana (NCNA), eFFECTOR Therapeutics (EFTR), ASLAN Pharmaceuticals (ASLN), Hepion Pharmaceuticals (HEPA), and Can-Fite BioPharma (CANF). These companies are all part of the "pharmaceutical preparations" industry.
Bionomics (NASDAQ:BNOX) and ObsEva (NASDAQ:OBSV) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, community ranking, earnings, risk, analyst recommendations, valuation, institutional ownership, profitability and media sentiment.
Bionomics has higher earnings, but lower revenue than ObsEva.
Bionomics has a beta of -0.08, suggesting that its share price is 108% less volatile than the S&P 500. Comparatively, ObsEva has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500.
Bionomics currently has a consensus target price of $9.00, indicating a potential upside of 846.27%.
15.9% of Bionomics shares are held by institutional investors. Comparatively, 17.5% of ObsEva shares are held by institutional investors. 1.5% of Bionomics shares are held by insiders. Comparatively, 14.4% of ObsEva shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
ObsEva received 303 more outperform votes than Bionomics when rated by MarketBeat users. However, 72.73% of users gave Bionomics an outperform vote while only 53.61% of users gave ObsEva an outperform vote.
ObsEva's return on equity of 0.00% beat Bionomics' return on equity.
In the previous week, Bionomics had 2 more articles in the media than ObsEva. MarketBeat recorded 3 mentions for Bionomics and 1 mentions for ObsEva. ObsEva's average media sentiment score of 1.58 beat Bionomics' score of 0.00 indicating that Bionomics is being referred to more favorably in the media.
Summary
Bionomics beats ObsEva on 7 of the 12 factors compared between the two stocks.
Get ObsEva News Delivered to You Automatically
Sign up to receive the latest news and ratings for OBSV and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding OBSV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
